DIANA RAUCKMAN: Open Payments
NPI 1902885262 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,280 in 10 payments from 7 companies in 2025. Trend: 2023 $1,038 · 2024 $1,514 · 2025 $1,280
Food & beverage: $1,280
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $342 |
| AstraZeneca Pharmaceuticals LP | 2 | $263 |
| Medtronic, Inc. | 1 | $203 |
| Novo Nordisk Inc | 1 | $125 |
| Lundbeck LLC | 1 | $125 |
| Abbott Laboratories | 1 | $117 |
| Lilly USA, LLC | 1 | $105 |
Products named: INTERSTIM, FARXIGA, Ozempic, VYEPTI, AREXVY, SHINGRIX, BREZTRI, FREESTYLE LIBRE 3.
Industry payments across AZ — which companies pay providers there.
